What is Centile Bio?
Centile Bio operates at the intersection of artificial intelligence and medical imaging, offering a proprietary AI-powered neuroimaging analytics platform. This technology transforms standard MRI and CT scans into precise, quantitative brain biomarkers and comprehensive reference models. By integrating advanced imaging analytics, machine learning algorithms, and sophisticated computational modeling, Centile Bio's platform is poised to significantly enhance diagnostics, streamline clinical trials, and accelerate neuroscience research.
How much funding has Centile Bio raised?
Centile Bio has raised a total of $3.1M across 1 funding round:
Private Equity
$3.1M
Private Equity (2026): $3.1M, investors not publicly disclosed
What's next for Centile Bio?
The recent major strategic investment signals a pivotal growth phase for Centile Bio. This capital is expected to fuel the expansion of its AI-powered neuroimaging analytics platform, potentially enabling broader market penetration and the development of new applications in diagnostic and research settings. The company's focus on quantitative brain biomarkers positions it for substantial impact in precision medicine and neurological disorder management.
See full Centile Bio company page
